Principal Securities Inc. Has $34.60 Million Stake in iShares Core S&P Small-Cap ETF (NYSEARCA:IJR)
Principal Securities Inc. grew its stake in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by 20.7% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 295,818 shares of the exchange traded fund’s stock after buying an additional 50,754 shares during the period. iShares Core […]
Hudson Valley Investment Advisors Inc. ADV Lowers Stake in iShares S&P 500 Growth ETF (NYSEARCA:IVW)
Hudson Valley Investment Advisors Inc. ADV trimmed its holdings in iShares S&P 500 Growth ETF (NYSEARCA:IVW – Free Report) by 13.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,950 shares of the company’s stock after selling 450 shares during the period. Hudson Valley Investment Advisors Inc. […]
Principal Securities Inc. Has $18.20 Million Holdings in iShares Core S&P U.S. Growth ETF (NASDAQ:IUSG)
Principal Securities Inc. increased its holdings in iShares Core S&P U.S. Growth ETF (NASDAQ:IUSG – Free Report) by 1.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 137,931 shares of the company’s stock after acquiring an additional 2,492 shares during the period. […]
Principal Securities Inc. Acquires 301 Shares of iShares Core U.S. Aggregate Bond ETF (NYSEARCA:AGG)
Principal Securities Inc. lifted its stake in shares of iShares Core U.S. Aggregate Bond ETF (NYSEARCA:AGG – Free Report) by 0.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 996,327 shares of the company’s stock after acquiring an additional 301 shares during the quarter. […]
Hudson Valley Investment Advisors Inc. ADV Has $403,000 Position in Amgen Inc. (NASDAQ:AMGN)
Hudson Valley Investment Advisors Inc. ADV cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 29.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,250 shares of the medical research company’s stock after selling 510 shares during the period. Hudson Valley Investment […]
last updated on 1 Nov 13:30